| 1 | [SID856022] | Active | Potency | 0.0065 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor [AID588790, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | Potency | 0.0065 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor | | AID | 588790 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 2 | [SID856022] | Active | Potency | 0.0065 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor [AID588790, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | Potency | 0.0065 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor | | AID | 588790 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 3 | [SID856022] | Active | Potency | 0.0065 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor [AID588790, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | Potency | 0.0065 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor | | AID | 588790 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 4 | [SID856022] | Active | Potency | 0.0065 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor [AID588790, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | Potency | 0.0065 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor | | AID | 588790 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 5 | [SID856022] | Active | Potency | 1.9953 | qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway [AID915, Type: confirmatory] | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) [Homo sapien [gi:32879895] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway | | AID | 915 | | BioAssay type | confirmatory | | Target | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) [Homo sapien [gi:32879895] | | PubMed | | | Data Table |  |
|
| 6 | [SID856022] | Active | Potency | 1.9953 | qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway [AID915, Type: confirmatory] | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) [Homo sapien [gi:32879895] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway | | AID | 915 | | BioAssay type | confirmatory | | Target | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) [Homo sapien [gi:32879895] | | PubMed | | | Data Table |  |
|
| 7 | [SID856022] | Active | Potency | 1.9953 | qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway [AID915, Type: confirmatory] | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) [Homo sapien [gi:32879895] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway | | AID | 915 | | BioAssay type | confirmatory | | Target | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) [Homo sapien [gi:32879895] | | PubMed | | | Data Table |  |
|
| 8 | [SID856022] | Active | Potency | 2.0596 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation [AID588463, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | Potency | 2.0596 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation | | AID | 588463 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 9 | [SID856022] | Active | Potency | 2.0596 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation [AID588463, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | Potency | 2.0596 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation | | AID | 588463 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 10 | [SID856022] | Active | Potency | 2.0596 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation [AID588463, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | Potency | 2.0596 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation | | AID | 588463 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 11 | [SID856022] | Active | Potency | 2.0596 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation [AID588463, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | Potency | 2.0596 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation | | AID | 588463 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 12 | [SID856022] | Active | Potency | 2.8117 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | Potency | 2.8117 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 13 | [SID856022] | Active | Potency | 3.1623 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 14 | [SID856022] | Active | Potency | 3.1623 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 15 | [SID856022] | Active | Potency | 3.1623 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 16 | [SID856022] | Active | Potency | 3.1623 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 17 | [SID56422893] | Active | EC50 | 3.84 | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 [AID588763, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 56422893 | | CID | 23702 | | Outcome | Active | | EC50 | 3.84 [uM] | | BioAssay | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 | | AID | 588763 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 18 | [SID56422893] | Active | EC50 | 3.84 | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 [AID588763, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 56422893 | | CID | 23702 | | Outcome | Active | | EC50 | 3.84 [uM] | | BioAssay | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 | | AID | 588763 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 19 | [SID56422893] | Active | EC50 | 3.84 | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 [AID588763, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 56422893 | | CID | 23702 | | Outcome | Active | | EC50 | 3.84 [uM] | | BioAssay | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 | | AID | 588763 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 20 | [SID56422893] | Active | EC50 | 3.84 | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 [AID588763, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 56422893 | | CID | 23702 | | Outcome | Active | | EC50 | 3.84 [uM] | | BioAssay | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 | | AID | 588763 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 21 | [SID103771136] | Active | IC50 | 6.30957 | Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay [AID524793, Type: Literature] | |   View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103771136 | | CID | 23702 | | Outcome | Active | | IC50 | 6.30957 [uM] | | BioAssay | Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay | | AID | 524793 | | BioAssay type | Literature | | Target | | | PubMed | 19734910 | | Data Table |  |
|
| 22 | [SID50106482] | Active | Potency | 7.0795 | qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2 [AID1882, Type: confirmatory] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 50106482 | | CID | 23702 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2 | | AID | 1882 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID103771136] | Active | IC50 | 7.94328 | Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay [AID524795, Type: Literature] | |   View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103771136 | | CID | 23702 | | Outcome | Active | | IC50 | 7.94328 [uM] | | BioAssay | Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay | | AID | 524795 | | BioAssay type | Literature | | Target | | | PubMed | 19734910 | | Data Table |  |
|
| 24 | [SID50106482] | Active | Potency | 8.9125 | qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2 [AID1883, Type: confirmatory] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 50106482 | | CID | 23702 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2 | | AID | 1883 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID50106482] | Active | Potency | 8.9125 | qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3 [AID1886, Type: confirmatory] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 50106482 | | CID | 23702 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3 | | AID | 1886 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID103771136] | Active | IC50 | 10 | Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay [AID524796, Type: Literature] | |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103771136 | | CID | 23702 | | Outcome | Active | | IC50 | 10 [uM] | | BioAssay | Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay | | AID | 524796 | | BioAssay type | Literature | | Target | | | PubMed | 19734910 | | Data Table |  |
|
| 27 | [SID103771136] | Active | IC50 | 10 | Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay [AID524791, Type: Literature] | |   View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103771136 | | CID | 23702 | | Outcome | Active | | IC50 | 10 [uM] | | BioAssay | Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay | | AID | 524791 | | BioAssay type | Literature | | Target | | | PubMed | 19734910 | | Data Table |  |
|
| 28 | [SID50106482] | Active | Potency | 11.2202 | qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8 [AID1815, Type: confirmatory] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 50106482 | | CID | 23702 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8 | | AID | 1815 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID103771136] | Active | IC50 | 12.5892 | Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay [AID524792, Type: Literature] | |   View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103771136 | | CID | 23702 | | Outcome | Active | | IC50 | 12.5892 [uM] | | BioAssay | Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay | | AID | 524792 | | BioAssay type | Literature | | Target | | | PubMed | 19734910 | | Data Table |  |
|
| 30 | [SID103771136] | Active | IC50 | 12.5892 | Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay [AID524794, Type: Literature] | |   View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103771136 | | CID | 23702 | | Outcome | Active | | IC50 | 12.5892 [uM] | | BioAssay | Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay | | AID | 524794 | | BioAssay type | Literature | | Target | | | PubMed | 19734910 | | Data Table |  |
|
| 31 | [SID103771136] | Active | IC50 | 12.5892 | Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay [AID524790, Type: Literature] | |   View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103771136 | | CID | 23702 | | Outcome | Active | | IC50 | 12.5892 [uM] | | BioAssay | Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay | | AID | 524790 | | BioAssay type | Literature | | Target | | | PubMed | 19734910 | | Data Table |  |
|
| 32 | [SID50106482] | Active | Potency | 12.5893 | qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4 [AID1816, Type: confirmatory] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 50106482 | | CID | 23702 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4 | | AID | 1816 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID50106482] | Active | Potency | 12.5893 | qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7 [AID1876, Type: confirmatory] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 50106482 | | CID | 23702 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7 | | AID | 1876 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID50106482] | Active | Potency | 12.5893 | qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10 [AID1877, Type: confirmatory] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 50106482 | | CID | 23702 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10 | | AID | 1877 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID856022] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 36 | [SID856022] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2147, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2147 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 37 | [SID50106482] | Active | Potency | 15.8489 | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2147, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 50106482 | | CID | 23702 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2147 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 38 | [SID856022] | Active | EC50 | 20.671 | High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression - Dose Response [AID1045, Type: confirmatory] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | EC50 | 20.671 [uM] | | BioAssay | High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression - Dose Response | | AID | 1045 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID856022] | Active | EC50 | 24.1 | High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor - Dose Response [AID1047, Type: confirmatory] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | EC50 | 24.1 [uM] | | BioAssay | High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor - Dose Response | | AID | 1047 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID856022] | Active | EC50 | 125.376 | Fluorescent Polarization Homogeneous Dose Response HTS to Indentify Inhibitors of Mex-5 Binding to TCR-2 [AID1960, Type: confirmatory] | Zinc finger protein mex- [gi:55976631] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | EC50 | 125.376 [uM] | | BioAssay | Fluorescent Polarization Homogeneous Dose Response HTS to Indentify Inhibitors of Mex-5 Binding to TCR-2 | | AID | 1960 | | BioAssay type | confirmatory | | Target | Zinc finger protein mex- [gi:55976631] | | PubMed | | | Data Table |  |
|
| 41 | [SID856022] | Active | EC50 | 125.376 | Fluorescent Polarization Homogeneous Dose Response HTS to Indentify Inhibitors of Mex-5 Binding to TCR-2 [AID1960, Type: confirmatory] | Zinc finger protein mex- [gi:55976631] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | EC50 | 125.376 [uM] | | BioAssay | Fluorescent Polarization Homogeneous Dose Response HTS to Indentify Inhibitors of Mex-5 Binding to TCR-2 | | AID | 1960 | | BioAssay type | confirmatory | | Target | Zinc finger protein mex- [gi:55976631] | | PubMed | | | Data Table |  |
|
| 42 | [SID856022] | Active | | | MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen [AID1832, Type: screening] | Zinc finger protein mex- [gi:55976631] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | BioAssay | MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen | | AID | 1832 | | BioAssay type | screening | | Target | Zinc finger protein mex- [gi:55976631] | | PubMed | | | Data Table |  |
|
| 43 | [SID856022] | Active | | | MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen [AID1832, Type: screening] | Zinc finger protein mex- [gi:55976631] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | BioAssay | MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen | | AID | 1832 | | BioAssay type | screening | | Target | Zinc finger protein mex- [gi:55976631] | | PubMed | | | Data Table |  |
|
| 44 | [SID856022] | Active | | | Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling [AID588627, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling | | AID | 588627 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 45 | [SID856022] | Active | | | Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling [AID588627, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling | | AID | 588627 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 46 | [SID17405232] | Active | | | Modulators of the EP2 prostaglandin E2 receptor - Primary Screening [AID940, Type: screening] | prostaglandin E receptor 2 (subtype EP2), 53kDa [Homo sapiens] [gi:31881630] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 17405232 | | CID | 23702 | | Outcome | Active | | BioAssay | Modulators of the EP2 prostaglandin E2 receptor - Primary Screening | | AID | 940 | | BioAssay type | screening | | Target | prostaglandin E receptor 2 (subtype EP2), 53kDa [Homo sapiens] [gi:31881630] | | PubMed | | | Data Table |  |
|
| 47 | [SID17405232] | Active | | | Modulators of the EP2 prostaglandin E2 receptor - Primary Screening [AID940, Type: screening] | prostaglandin E receptor 2 (subtype EP2), 53kDa [Homo sapiens] [gi:31881630] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 17405232 | | CID | 23702 | | Outcome | Active | | BioAssay | Modulators of the EP2 prostaglandin E2 receptor - Primary Screening | | AID | 940 | | BioAssay type | screening | | Target | prostaglandin E receptor 2 (subtype EP2), 53kDa [Homo sapiens] [gi:31881630] | | PubMed | | | Data Table |  |
|
| 48 | [SID856022] | Active | | | Allosteric Modulators of D1 Receptors: Primary Screen [AID641, Type: screening] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | BioAssay | Allosteric Modulators of D1 Receptors: Primary Screen | | AID | 641 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID856022] | Active | | | Allosteric Modulators of D1 Receptors: Confirmation Screen [AID642, Type: other] | |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | BioAssay | Allosteric Modulators of D1 Receptors: Confirmation Screen | | AID | 642 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 50 | [SID856022] | Active | | | Counter Screen for Glucose-6-Phosphate Dehydrogenase-based Primary Assay [AID1020, Type: screening] | glucose-6-phosphate dehydrogenase [Leuconostoc mesenteroides] [gi:149631] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 856022 | | CID | 23702 | | Outcome | Active | | BioAssay | Counter Screen for Glucose-6-Phosphate Dehydrogenase-based Primary Assay | | AID | 1020 | | BioAssay type | screening | | Target | glucose-6-phosphate dehydrogenase [Leuconostoc mesenteroides] [gi:149631] | | PubMed | | | Data Table |  |
|